do glp 1 drugs reduce inflammation 8 Benefits of GLP‑1's Beyond Weight Loss Your guide to GLP-1 side

Meyhfer S, Eckert AJ, Hummel M et al (2022) Elevated liver enzymes and comorbidities in type 2 diabetes: a multicentre analysis of 51 645 patients from the Diabetes Prospective Follow-up (DPV) database

The inclusion in our network analysis of the AMPLITUDE-O and EMPEROR-P data have modified the conclusions of the most recent similar analysis [15] indicating that SGLT-2 inhibitors increased the risk of stroke as compared with GLP-1RA and that GLP-1RA are superior to DPP-4 inhibitors as for nonfatal MI

[DOI] [PubMed] [Google Scholar] 77.Sanz C., Vzquez P., Blzquez C., Barrio P.A., Alvarez M.D.M., Blzquez E

Semaglutide joins liraglutide (Saxenda), which is another GLP-1 receptor agonist that was FDA-approved for weight management in 2014

Similar results of gliosis reduction have been shown after subcutaneous administration of exendin-4 to mice on HFDs [41]

At the same time, we are facing an exciting multifaceted future, with several novel developments on the horizon with the potential to change the clinic setting, including the development of oral GLP-1 receptor agonists and the emerging formulations of GIP receptor agonists and dual and triple receptor agonists, which have shown clear therapeutic potential